| Mar 19, 2013
Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers saw an opportunity and raced to develop new medicines.
Today, as the world confronts the crisis of antibiotic resistance, the industry...
| Jul 16, 2012
| 4:00 PM
After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
GlaxoSmithKline boosted its offer for...
| Nov 18, 2012
When Gail Folena-Wasserman joined Gaithersburg biotechnology startup MedImmune in 1991, she was its first employee in research and development, and dreamed of what the company might be "when it grew up."
Two decades later, the senior vice president for...
| Mar 15, 2012
| 6:11 PM
Maryland succeeded in raising $84 million to invest in promising technology companies across the state via a novel online auction of tax credits, officials announced Thursday.
The InvestMaryland plan, a cornerstone of Gov. Martin O'Malley's legislative...
| Feb 21, 2013
| 11:27 AM
Saint Agnes Hospital will work with local churches to screen for heart disease, using a $244,455 grant from The AstraZeneca HealthCare Foundation.
The hospital announced Thursday that it had received the award.
The screening program will focus on...
| Sep 30, 2011
In this week’s coverage of the trial of Michael Jackson’s personal physician, Dr. Conrad Murray, articles have been consistent in describing the drug that killed the pop star: Tuesday: “the dangerous surgical anesthetic propofol”...
| Jan 13, 2009
You might conclude that stock dividends are harder to find these days than, say, a credit card company that forgives late payments.
Cash-strapped companies, most notably banks, slashed dividends last year to the tune of more than $40 billion.
It was the...
| Mar 9, 2009
Use of a cholesterol-lowering statin drug resulted in big reductions in heart attacks, strokes and deaths in people with so-called healthy cholesterol levels.
The benefit was so pronounced - a 54 percent reduction in heart attacks, a 48 percent reduction...
| Nov 11, 2009
Executives inside pharmaceutical giant AstraZeneca faced a high-stakes dilemma.
On one hand, Chicago psychiatrist Dr. Michael Reinstein was bringing the company a small fortune in sales and was conducting research that made one of its most promising...
| Dec 22, 2008
Should statin drugs be put in the water, or what?
More than 13 million Americans are taking these medications to lower their cholesterol and hopefully stave off heart disease -- a job the drugs appear to excel at. Statins can lower "bad" LDL...
| Oct 18, 2010
| 9:13 PM
Follow drug company money in Illinois, and it leads to the psychiatry department at Rush University Medical Center, a prominent headache clinic on the North Side of Chicago, a busy suburban urology practice and a psychiatric hospital accused of...